Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order

GLP1R / GLP-1 Receptor

glucagon-like peptide 1 receptor

GLP1R, a Glucagon Receptor, has been suggested to affect the feelings of satiety or hunger, sensation of glucose levels, control of glucagon sensitivity of islets, and non insulin-dependent diabetes mellitus. Glucagon-like peptide 1 is an incretin hormone produced by enteroendocrine L-cells in the intestinal mucosa. The hormone is released in response to food intake and plays an important role in maintaining blood glucose homeostasis. Stimulation of the GLP-1R by endogenous hormone induces multiple complementary mechanisms, which together result in a lowering of circulating blood glucose levels. These mechanisms include receptor-mediated enhancement of glucose-induced insulin secretion from pancreatic -cells, inhibition of gastric emptying with a delay in the gastrointestinal resorption of nutrients, inhibition of glucagon secretion, and inhibition of food intake. Desensitization of GLP1R on pancreatic beta-cells is one of the causes of non insulin-dependent diabetes mellitus (NIDDM). GLP1R knockout mice are viable, develop normally, but exhibit increased levels of blood glucose following oral glucose challenge in association with diminished levels of circulating insulin. Recently it has been shown that overexpression of glucagon-like peptide-1 receptor improves learning in rats (During et al. 2003).

Gene Name: glucagon-like peptide 1 receptor
Family/Subfamily: GPCR , Glucagon
Synonyms: GLP1R, GLP-1-R, GLP-1 receptor, GLP-1R, GLP-I receptor, Glp1 receptor
Target Sequences: NM_002062 NP_002053.3 P43220

Publications (12)

1
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Himeno T, Kamiya H, Naruse K, Harada N, Ozaki N, Seino Y, Shibata T, Kondo M, Kato J, Okawa T, Fukami A, Hamada Y, Inagaki N, Seino Y, Drucker DJ, Oiso Y, Nakamura J. Diabetes. 2011 60:2397-406. (IHC-Fr; Mouse) [Full Text Article] [PubMed:21810596] [PMC:PMC3161330] Related Antibodies: LS-A1206, LS-A1205.
2
Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. Lamont BJ, Li Y, Kwan E, Brown TJ, Gaisano H, Drucker DJ. The Journal of clinical investigation. 2012 122:388-402. (IHC; Mouse) [Full Text Article] [PubMed:22182839] [PMC:PMC3248276] Related Antibodies: LS-A1205.
3
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE–/– Mice. Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, Streutker C, Holland D, Cao X, Baggio LL, Drucker DJ. Endocrinology. 2013 154:127-39. (WB; Mouse, Hamster) [Full Text Article] [PubMed:23183176] Related Antibodies: LS-A1205.
4
The Glucagon-Like Peptide-1 Receptor—or Not?. Pyke C, Knudsen LB. Endocrinology. 2013 154:8-Apr. (IHC-P; Human) [Full Text Article] [PubMed:23267050] Related Antibodies: LS-A1206, LS-A1205.
5
Equine glucagon-like peptide-1 receptor physiology. Kheder MH, Bailey SR, Dudley KJ, Sillence MN, de Laat MA. PeerJ. 2018 January;6:e4316. (Human) [Full Text Article] [PubMed:29404215] [PMC:PMC5793710]
6
Expression of the GLP-1 receptor in mouse, rat, and human pancreas. Tornehave D, Kristensen P, R[Character f8]mer J, Knudsen LB, Heller RS. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 2013 Sep;56:841-51. [Full Text Article] [PubMed:18541709] [PMC:PMC2516959] Related Antibodies: LS-A1206.
7
Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist. Connolly BM, Vanko A, McQuade P, Guenther I, Meng X, Rubins D, Waterhouse R, Hargreaves R, Sur C, Hostetler E. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 2004 Feb;14:79-87. [Full Text Article] [PubMed:21394533] Related Antibodies: LS-A1206.
8
Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury. Hirata Y, Kurobe H, Nishio C, Tanaka K, Fukuda D, Uematsu E, Nishimoto S, Soeki T, Harada N, Sakaue H, Kitagawa T, Shimabukuro M, Nakaya Y, Sata M. European journal of pharmacology. 2013 Jan;699:106-11. [Full Text Article] [PubMed:23220706] Related Antibodies: LS-A1206.
9
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T, Fujitani Y, Hirose T, Kawamori R, Watada H. Diabetes. 2010 Apr;59:1030-7. [Full Text Article] [PubMed:20068138] [PMC:PMC2844811] Related Antibodies: LS-A1205.
10
GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ. Diabetes. 2009 Apr;58:975-83. [Full Text Article] [PubMed:19151200] [PMC:PMC2661586] Related Antibodies: LS-A1205.
11
IRS-2 deficiency in macrophages promotes their accumulation in the vascular wall. Mita T, Azuma K, Goto H, Jin WL, Arakawa M, Nomiyama T, Suzuki R, Kubota N, Tobe K, Kadowaki T, Fujitani Y, Hirose T, Kawamori R, Watada H. Biochemical and biophysical research communications. 2011 Dec;415:545-50. [Full Text Article] [PubMed:22074825] Related Antibodies: LS-A1205.
12
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. Baldassano S, Wang GD, Mul[Character e8] F, Wood JD. American journal of physiology. Gastrointestinal and liver physiology. 2012 Feb;302:G352-8. [Full Text Article] [PubMed:22075777] [PMC:PMC3287398] Related Antibodies: LS-A1205.
more

☰ Filters
Products
Proteins (14)
Over-Expression Lysate (2)
Recombinant (12)
GLP1R / GLP-1 Receptor (14)
No (14)
10His, N-terminus (3)
6His, N-terminus (4)
6His-SUMO, N-terminus (1)
Fc, C-terminus (2)
His (2)
Myc-DDK (Flag) (2)
Human (8)
Mouse (2)
Rat (3)
293T Cells (1)
Baculovirus (2)
E. coli (5)
HEK 293 Cells (1)
Mammalian Cells (3)
Yeast (2)
Purified (8)
Low endotoxin level (2)
GLP1R / GLP-1 Receptor Protein
Select
Yeast
His
16.3 kD
1 mg/$1,607; 100 µg/$469; 20 µg/$349
Select
E. coli
His
18.4 kD
1 mg/$1,355; 100 µg/$420; 20 µg/$323
GLP1R / GLP-1 Receptor Protein - Recombinant Glucagon Like Peptide 1 Receptor By SDS-PAGE
Select
E. coli
6His, N-terminus
21.5 kDa
10 µg/$283; 50 µg/$452; 100 µg/$722; 200 µg/$902; 1 mg/$2,016; 500 µg/$1,553; 5 mg/$3,151; 2 mg/$2,204
GLP1R / GLP-1 Receptor Protein - (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Select
E. coli
10His, N-terminus
53.6 kDa
100 µg/$1,293; 20 µg/$854
Select
Mammalian Cells
Fc, C-terminus
Less than 0.1 ng/mL (Less than 1 EU/µg) (determined by LAL method).
10 µg/$288; 50 µg/$442; 500 µg/$1,585; 1 mg/$2,157
GLP1R / GLP-1 Receptor Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
HEK 293 Cells
Myc-DDK (Flag)
52.8 kDa
100 µg/$494
Select
Mammalian Cells
Fc, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
41.2 kDa
10 µg/$288; 50 µg/$436
GLP1R / GLP-1 Receptor Protein - (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel. The reducing (R) protein migrates as 60 kDa in SDS-PAGE may be due to glycosylation.
Select
Yeast
6His, N-terminus
100 µg/$679; 20 µg/$429; 1 mg/$1,973
GLP1R / GLP-1 Receptor Protein - (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Select
E. coli
6His, N-terminus
1 mg/$1,679; 100 µg/$598; 20 µg/$405
GLP1R / GLP-1 Receptor Protein - (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Select
E. coli
6His-SUMO, N-terminus
1 mg/$1,679; 100 µg/$500; 20 µg/$364
GLP1R / GLP-1 Receptor Protein - (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Select
Baculovirus
10His, N-terminus
100 µg/$1,067; 20 µg/$447; 1 mg/$1,988
GLP1R / GLP-1 Receptor Protein - (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Select
Baculovirus
10His, N-terminus
100 µg/$1,067; 20 µg/$447; 1 mg/$1,988
GLP1R / GLP-1 Receptor Protein - (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Select
Mammalian Cells
6His, N-terminus
100 µg/$1,116; 20 µg/$461
GLP1R / GLP-1 Receptor Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
293T Cells
Myc-DDK (Flag)
52.8 kDa
20 µg/$150
Viewing 1-14 of 14 product results


Filtered By:
Products: Proteins


If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.

PLEASE NOTE

For RESEARCH USE ONLY. Intended for use by laboratory professionals. Not intended for human diagnostic or therapeutic purposes.

The data on this page has been compiled from LifeSpan internal sources, the National Center for Biotechnology Information (NCBI), and The Universal Protein Resource (UniProt).